首页> 美国卫生研究院文献>Biomedical Journal >The challenges of amblyopia treatment
【2h】

The challenges of amblyopia treatment

机译:弱视治疗的挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The treatment of amblyopia, particularly anisometropic (difference in refractive correction) and/or strabismic (turn of one eye) amblyopia has long been a challenge for many clinicians. Achieving optimum outcomes, where the amblyopic eye reaches a visual acuity similar to the fellow eye, is often impossible in many patients. Part of this challenge has resulted from a previous lack of scientific evidence for amblyopia treatment that was highlight by a systematic review by Snowdon et al. in 1998. Since this review, a number of publications have revealed new findings in the treatment of amblyopia. This includes the finding that less intensive occlusion treatments can be successful in treating amblyopia. A relationship between adherence to treatment and visual acuity has also been established and has been shown to be influenced by the use of intervention material. In addition, there is growing evidence of that a period of glasses wearing only can significantly improve visual acuity alone without any other modes of treatment. This review article reports findings since the Snowdon's report.
机译:长期以来,弱视,尤其是屈光参差(屈光矫正的差异)和/或斜视(单眼)弱视的治疗一直是许多临床医生面临的挑战。在许多患者中,实现弱视眼达到与另一只眼睛相似的视力的最佳结果通常是不可能的。这项挑战的部分原因是由于先前缺乏弱视治疗的科学证据,Snowdon等人的系统评价突显了这一点。自从1998年以来,许多出版物已经揭示了弱视治疗的新发现。这包括发现,强度较低的闭塞治疗可成功治疗弱视。还建立了坚持治疗与视敏度之间的关系,并显示其受干预材料使用的影响。此外,越来越多的证据表明,仅戴眼镜一段时间可以单独改善视敏度,而无需任何其他治疗方式。这篇评论文章报告了自Snowdon报告以来的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号